RecruitingNot ApplicableNCT06330441

Pancreatic Cancer Screening in a Population at High Risk


Sponsor

Masaryk Memorial Cancer Institute

Enrollment

700 participants

Start Date

Jan 7, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Pancreatic cancer is one of the diseases with the worst prognosis, which is mainly due to the initial asymptomatic prognosis. Unfortunately, the incidence of this disease in the Czech Republic is still increasing. In a certain proportion of patients, it is possible to predict the disease, e.g. due to family burdens. Regular follow-up of such individuals is the subject of the SCREPAN study: "Pancreatic Cancer Screening in High-Risk Persons".


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is offering structured surveillance (regular monitoring and early detection screening) for pancreatic cancer in people who are at higher-than-average risk due to genetic mutations, hereditary syndromes, family history, or chronic pancreatic conditions. Early detection dramatically improves outcomes for pancreatic cancer, which is often caught too late. **You may be eligible if:** - You are 18 or older and willing to participate - You have chronic pancreatic disease due to cystic fibrosis or chronic pancreatitis (and are age 50+) - You carry a gene mutation linked to hereditary cancer syndromes (such as Peutz-Jeghers, CDKN2A, PRSS1, Lynch syndrome, BRCA1/2, PALB2, ATM, APC, TP53 and others) combined with a qualifying age or family history of pancreatic cancer - You have a strong family history of pancreatic cancer without a known hereditary syndrome (and are age 50+, or 10 years younger than the youngest affected relative) **You may NOT be eligible if:** - You are medically unable to undergo curative surgery if cancer were found - You do not meet age or risk-factor requirements for any of the study arms Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREendoscopic ultrasonography

endoscopic ultrasonography - frequency defined by arm

PROCEDUREmagnetic resonance

magnetic resonance - frequency defined by arm

DIAGNOSTIC_TESTlaboratory examination

hematology, biochemistry, Na+, K+, Cl-, Ca2+, bilirubin, ALT, AST, GGT, ALP, lactate dehydrogenase, creatinine, urea, fasting glycemia, HbA1c, alpha-amylase, LPS, albumin, total protein, CA19-9, CEA


Locations(1)

Masaryk Memorial Cancer Institute

Brno, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06330441


Related Trials